Yvonne Y.Y. Tsang

Learn More
BACKGROUND The Oncotype DX Breast Cancer Assay is validated to assess risk of distant recurrence and likelihood of chemotherapy (CT) benefit in estrogen receptor-positive ESBC in various populations.(More)
  • 1